Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients-Reference-Cited by-同舟云学术

Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients

Published:2018-02-10 Issue:2 Volume:10 Page:196
ISSN:2072-6643
Container-title:Nutrients
language:en
Short-container-title:Nutrients

Author:

Zheng Cai-Mei,Wu Chia-Chao,Hung Chi-Feng,Liao Min-Tser,Shyu Jia-Fwu,Hsu Yung-Ho,Lu Chien-Lin,Wang Yuan-Hung,Zheng Jing-Quan,Chang Tian-Jong,Lin Yuh-Feng^ORCID,Lu Kuo-Cheng

Publisher

MDPI AG

Subject

Food Science,Nutrition and Dietetics

Link

http://www.mdpi.com/2072-6643/10/2/196/pdf

Reference44 articles.

1. Clinical epidemiology of cardiovascular disease in chronic renal disease

2. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia;Massry;Semin. Nephrol.,1994

3. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy

4. Role of Local Versus Systemic Vitamin D Receptors in Vascular Calcification

5. Cinacalcet Hydrochloride (Sensipar) in Hemodialysis Patients on Active Vitamin D Derivatives with Controlled PTH and Elevated Calcium × Phosphate

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcitriol Versus Calcitriol and Low Dose Cinacalcet for Treating Severe Secondary Hyperparathyroidism in Hemodialysis Patients: A Randomized Clinical Trial;Journal of Kermanshah University of Medical Sciences;2023-08-06

2. Does Native Vitamin D Supplementation Have Pleiotropic Effects in Patients with End-Stage Kidney Disease? A Systematic Review of Randomized Trials;Nutrients;2023-07-07

3. Serum nuclear factor IB as a novel and noninvasive indicator in the diagnosis of secondary hyperparathyroidism;Journal of Clinical Laboratory Analysis;2021-05-15

4. Therapeutic Effect of Calcimimetics on Osteoclast–Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease;International Journal of Molecular Sciences;2020-11-18

5. Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial;Scientific Reports;2020-09-23